CD4 mimetics sensitize HIV-1-infected cells to ADCC

Jonathan Richard, Maxime Veillette, Nathalie Brassard, Shilpa S. Iyer, Michel Roger, Loïc Martin, Marzena Pazgier, Arne Schön, Ernesto I Freire, Jean Pierre Routy, Amos B. Smith, Jongwoo Park, David M. Jones, Joel R. Courter, Bruno N. Melillo, Daniel E. Kaufmann, Beatrice H. Hahn, Sallie R. Permar, Barton F. Haynes, Navid MadaniJoseph G. Sodroski, Andrés Finzi

Research output: Contribution to journalArticle

Abstract

HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cell-mediated cytotoxicity (ADCC). HIV-1 has evolved a sophisticated mechanism to avoid exposure of ADCC-mediating Env epitopes by down-regulating CD4 and by limiting the overall amount of Env at the cell surface. Here we report that small-molecule CD4-mimetic compounds induce the CD4-bound conformation of Env, and thereby sensitize cells infected with primary HIV-1 isolates to ADCC mediated by antibodies present in sera, cervicovaginal lavages, and breast milk from HIV-1-infected individuals. Importantly, we identified one CD4 mimetic with the capacity to sensitize endogenously infected ex vivo-amplified primary CD4 T cells to ADCC killing mediated by autologous sera and effector cells. Thus, CD4 mimetics hold the promise of therapeutic utility in preventing and controlling HIV-1 infection.

Original languageEnglish (US)
Pages (from-to)E2687-E2694
JournalProceedings of the National Academy of Sciences of the United States of America
Volume112
Issue number20
DOIs
StatePublished - May 19 2015

Fingerprint

Antibody-Dependent Cell Cytotoxicity
HIV-1
env Gene Products
CD4 Antigens
Therapeutic Irrigation
Human Milk
Serum
HIV Infections
Epitopes
T-Lymphocytes
Antibodies

Keywords

  • ADCC
  • CD4 mimetics
  • Envelope glycoproteins
  • gp120
  • HIV-1

ASJC Scopus subject areas

  • General

Cite this

Richard, J., Veillette, M., Brassard, N., Iyer, S. S., Roger, M., Martin, L., ... Finzi, A. (2015). CD4 mimetics sensitize HIV-1-infected cells to ADCC. Proceedings of the National Academy of Sciences of the United States of America, 112(20), E2687-E2694. https://doi.org/10.1073/pnas.1506755112

CD4 mimetics sensitize HIV-1-infected cells to ADCC. / Richard, Jonathan; Veillette, Maxime; Brassard, Nathalie; Iyer, Shilpa S.; Roger, Michel; Martin, Loïc; Pazgier, Marzena; Schön, Arne; Freire, Ernesto I; Routy, Jean Pierre; Smith, Amos B.; Park, Jongwoo; Jones, David M.; Courter, Joel R.; Melillo, Bruno N.; Kaufmann, Daniel E.; Hahn, Beatrice H.; Permar, Sallie R.; Haynes, Barton F.; Madani, Navid; Sodroski, Joseph G.; Finzi, Andrés.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 20, 19.05.2015, p. E2687-E2694.

Research output: Contribution to journalArticle

Richard, J, Veillette, M, Brassard, N, Iyer, SS, Roger, M, Martin, L, Pazgier, M, Schön, A, Freire, EI, Routy, JP, Smith, AB, Park, J, Jones, DM, Courter, JR, Melillo, BN, Kaufmann, DE, Hahn, BH, Permar, SR, Haynes, BF, Madani, N, Sodroski, JG & Finzi, A 2015, 'CD4 mimetics sensitize HIV-1-infected cells to ADCC', Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 20, pp. E2687-E2694. https://doi.org/10.1073/pnas.1506755112
Richard, Jonathan ; Veillette, Maxime ; Brassard, Nathalie ; Iyer, Shilpa S. ; Roger, Michel ; Martin, Loïc ; Pazgier, Marzena ; Schön, Arne ; Freire, Ernesto I ; Routy, Jean Pierre ; Smith, Amos B. ; Park, Jongwoo ; Jones, David M. ; Courter, Joel R. ; Melillo, Bruno N. ; Kaufmann, Daniel E. ; Hahn, Beatrice H. ; Permar, Sallie R. ; Haynes, Barton F. ; Madani, Navid ; Sodroski, Joseph G. ; Finzi, Andrés. / CD4 mimetics sensitize HIV-1-infected cells to ADCC. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 ; Vol. 112, No. 20. pp. E2687-E2694.
@article{3b079291d08f474587420cbacb2d7ae0,
title = "CD4 mimetics sensitize HIV-1-infected cells to ADCC",
abstract = "HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cell-mediated cytotoxicity (ADCC). HIV-1 has evolved a sophisticated mechanism to avoid exposure of ADCC-mediating Env epitopes by down-regulating CD4 and by limiting the overall amount of Env at the cell surface. Here we report that small-molecule CD4-mimetic compounds induce the CD4-bound conformation of Env, and thereby sensitize cells infected with primary HIV-1 isolates to ADCC mediated by antibodies present in sera, cervicovaginal lavages, and breast milk from HIV-1-infected individuals. Importantly, we identified one CD4 mimetic with the capacity to sensitize endogenously infected ex vivo-amplified primary CD4 T cells to ADCC killing mediated by autologous sera and effector cells. Thus, CD4 mimetics hold the promise of therapeutic utility in preventing and controlling HIV-1 infection.",
keywords = "ADCC, CD4 mimetics, Envelope glycoproteins, gp120, HIV-1",
author = "Jonathan Richard and Maxime Veillette and Nathalie Brassard and Iyer, {Shilpa S.} and Michel Roger and Lo{\"i}c Martin and Marzena Pazgier and Arne Sch{\"o}n and Freire, {Ernesto I} and Routy, {Jean Pierre} and Smith, {Amos B.} and Jongwoo Park and Jones, {David M.} and Courter, {Joel R.} and Melillo, {Bruno N.} and Kaufmann, {Daniel E.} and Hahn, {Beatrice H.} and Permar, {Sallie R.} and Haynes, {Barton F.} and Navid Madani and Sodroski, {Joseph G.} and Andr{\'e}s Finzi",
year = "2015",
month = "5",
day = "19",
doi = "10.1073/pnas.1506755112",
language = "English (US)",
volume = "112",
pages = "E2687--E2694",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "20",

}

TY - JOUR

T1 - CD4 mimetics sensitize HIV-1-infected cells to ADCC

AU - Richard, Jonathan

AU - Veillette, Maxime

AU - Brassard, Nathalie

AU - Iyer, Shilpa S.

AU - Roger, Michel

AU - Martin, Loïc

AU - Pazgier, Marzena

AU - Schön, Arne

AU - Freire, Ernesto I

AU - Routy, Jean Pierre

AU - Smith, Amos B.

AU - Park, Jongwoo

AU - Jones, David M.

AU - Courter, Joel R.

AU - Melillo, Bruno N.

AU - Kaufmann, Daniel E.

AU - Hahn, Beatrice H.

AU - Permar, Sallie R.

AU - Haynes, Barton F.

AU - Madani, Navid

AU - Sodroski, Joseph G.

AU - Finzi, Andrés

PY - 2015/5/19

Y1 - 2015/5/19

N2 - HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cell-mediated cytotoxicity (ADCC). HIV-1 has evolved a sophisticated mechanism to avoid exposure of ADCC-mediating Env epitopes by down-regulating CD4 and by limiting the overall amount of Env at the cell surface. Here we report that small-molecule CD4-mimetic compounds induce the CD4-bound conformation of Env, and thereby sensitize cells infected with primary HIV-1 isolates to ADCC mediated by antibodies present in sera, cervicovaginal lavages, and breast milk from HIV-1-infected individuals. Importantly, we identified one CD4 mimetic with the capacity to sensitize endogenously infected ex vivo-amplified primary CD4 T cells to ADCC killing mediated by autologous sera and effector cells. Thus, CD4 mimetics hold the promise of therapeutic utility in preventing and controlling HIV-1 infection.

AB - HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cell-mediated cytotoxicity (ADCC). HIV-1 has evolved a sophisticated mechanism to avoid exposure of ADCC-mediating Env epitopes by down-regulating CD4 and by limiting the overall amount of Env at the cell surface. Here we report that small-molecule CD4-mimetic compounds induce the CD4-bound conformation of Env, and thereby sensitize cells infected with primary HIV-1 isolates to ADCC mediated by antibodies present in sera, cervicovaginal lavages, and breast milk from HIV-1-infected individuals. Importantly, we identified one CD4 mimetic with the capacity to sensitize endogenously infected ex vivo-amplified primary CD4 T cells to ADCC killing mediated by autologous sera and effector cells. Thus, CD4 mimetics hold the promise of therapeutic utility in preventing and controlling HIV-1 infection.

KW - ADCC

KW - CD4 mimetics

KW - Envelope glycoproteins

KW - gp120

KW - HIV-1

UR - http://www.scopus.com/inward/record.url?scp=84929590788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929590788&partnerID=8YFLogxK

U2 - 10.1073/pnas.1506755112

DO - 10.1073/pnas.1506755112

M3 - Article

C2 - 25941367

AN - SCOPUS:84929590788

VL - 112

SP - E2687-E2694

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 20

ER -